| review article | Q7318358 |
| scholarly article | Q13442814 |
| P2093 | author name string | E Van Cutsem | |
| C Verslype | |||
| H Prenen | |||
| P2860 | cites work | Phase III study of 5FU, etoposide and leucovorin (FELV) compared to epirubicin, cisplatin and 5FU (ECF) in previously untreated patients with advanced biliary cancer | Q33214444 |
| Phase II study of systemic gemcitabine chemotherapy for advanced unresectable hepatobiliary carcinomas | Q33338191 | ||
| A phase II study of gemcitabine in gallbladder carcinoma | Q33340368 | ||
| Optimization of 5-fluorouracil (5-FU)/cisplatin combination chemotherapy with a new schedule of leucovorin, 5-FU and cisplatin (LV5FU2-P regimen) in patients with biliary tract carcinoma | Q33343774 | ||
| Mitomycin C in combination with capecitabine or biweekly high-dose gemcitabine in patients with advanced biliary tract cancer: a randomised phase II trial | Q33359839 | ||
| Gemcitabine combined with oxaliplatin (GEMOX) in advanced biliary tract adenocarcinoma: a GERCOR study | Q33362191 | ||
| Single-agent gemcitabine in the treatment of advanced biliary tract cancers: a phase II study | Q33364964 | ||
| A phase II trial of S-1 and cisplatin in patients with metastatic or relapsed biliary tract cancer | Q33376617 | ||
| Biliary tract cancers. | Q33760399 | ||
| Effects of 5-fluorouracil and leucovorin in the treatment of pancreatic-biliary tract adenocarcinomas | Q33914989 | ||
| Phase II study of erlotinib in patients with advanced biliary cancer | Q33997258 | ||
| Chemotherapy improves survival and quality of life in advanced pancreatic and biliary cancer | Q34063503 | ||
| A randomised phase II trial of weekly high-dose 5-fluorouracil with and without folinic acid and cisplatin in patients with advanced biliary tract carcinoma: results of the 40955 EORTC trial. | Q34554801 | ||
| Chemotherapy in advanced biliary tract carcinoma: a pooled analysis of clinical trials | Q34576456 | ||
| Capecitabine plus oxaliplatin as first-line treatment in patients with advanced biliary system adenocarcinoma: a prospective multicentre phase II trial | Q36614800 | ||
| Phase II study of S-1 in patients with advanced biliary tract cancer | Q36696249 | ||
| Bile acids induce cyclooxygenase-2 expression via the epidermal growth factor receptor in a human cholangiocarcinoma cell line | Q40742867 | ||
| Cetuximab plus gemcitabine-oxaliplatin (GEMOX) in patients with refractory advanced intrahepatic cholangiocarcinomas | Q46891324 | ||
| Long-term survival and metastatic pattern of pancreatic and periampullary cancer after adjuvant chemoradiation or observation: long-term results of EORTC trial 40891. | Q46925466 | ||
| A Phase II study of gemcitabine and cisplatin in advanced biliary tract cancer | Q46941755 | ||
| Adjuvant combination chemotherapy (AMF) following radical resection of carcinoma of the pancreas and papilla of Vater--results of a controlled, prospective, randomised multicentre study | Q70655757 | ||
| Staging, resectability, and outcome in 225 patients with hilar cholangiocarcinoma | Q74558715 | ||
| Weekly 24 h infusion of high-dose 5-fluorouracil and leucovorin in patients with biliary tract carcinomas | Q74770975 | ||
| Expanded phase II trial of gemcitabine and capecitabine for advanced biliary cancer | Q80605580 | ||
| Liver transplantation with neoadjuvant chemoradiation is more effective than resection for hilar cholangiocarcinoma | Q81148310 | ||
| P433 | issue | 3 | |
| P921 | main subject | gemcitabine | Q414143 |
| chemotherapy | Q974135 | ||
| P304 | page(s) | 164-167 | |
| P577 | publication date | 2008-01-01 | |
| P1433 | published in | Hepato Pancreato Biliary | Q15756742 |
| P1476 | title | The role of chemotherapy in biliary tract carcinoma | |
| P478 | volume | 10 |
| Q37818299 | Advances in photodynamic therapy for the treatment of hilar biliary tract cancer |
| Q41698384 | Analysis of Endoscopic Radiofrequency Ablation of Biliary Malignant Strictures in Pancreatic Cancer Suggests Potential Survival Benefit |
| Q37549918 | Are RAS mutations predictive markers of resistance to standard chemotherapy? |
| Q43271382 | Biliary drainage, photodynamic therapy and chemotherapy for unresectable cholangiocarcinoma with jaundice |
| Q51340875 | Chemotherapy for inoperable advanced or metastatic cholangiocarcinoma: retrospective analysis of 78 cases in a single center over four years. |
| Q34775386 | Clinical effect of a positive surgical margin after hepatectomy on survival of patients with intrahepatic cholangiocarcinoma |
| Q33849781 | Differential expression of cholecystokinin A receptor in gallbladder cancer in the young and elderly suggests two subsets of the same disease? |
| Q34654186 | Intra-arterial therapy for advanced intrahepatic cholangiocarcinoma: a multi-institutional analysis. |
| Q38607490 | Intrahepatic chemotherapy for unresectable cholangiocarcinoma: review of literature and personal experience |
| Q45027102 | Outcomes in unresectable and locally advanced resected cholangiocarcinoma |
| Q48282393 | Pancreatoduodenectomy with portal vein resection for distal cholangiocarcinoma. |
| Q34627947 | Phase II study of S-1 combined with oxaliplatin as therapy for patients with metastatic biliary tract cancer: influence of the CYP2A6 polymorphism on pharmacokinetics and clinical activity |
| Q37362900 | Repetitive response to gemcitabine that led to curative resection in cholangiocarcinoma |
Search more.